TRAVERE THERAPEUTICS, INC.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $620.3M | $828.4M | $256.6M |
| Jun 2022 | $622.8M | $779.5M | $179.8M |
| Sep 2022 | $625.5M | $726.2M | $151.3M |
| Dec 2022 | $629.7M | $672.6M | $61.7M |
| Mar 2023 | $619.1M | $808.2M | $161.4M |
| Jun 2023 | $619.9M | $736.4M | $70.9M |
| Sep 2023 | $553.1M | $832.9M | $144.2M |
| Dec 2023 | $588.1M | $788.9M | $58.2M |
| Mar 2024 | $589.5M | $663.5M | $43.3M |
| Jun 2024 | $536.0M | $551.1M | $32.3M |
| Sep 2024 | $534.9M | $504.4M | $36.4M |
| Dec 2024 | $535.0M | $594.1M | $58.5M |
| Mar 2025 | $516.0M | $548.8M | $61.9M |
| Jun 2025 | $522.6M | $555.3M | $75.2M |
| Sep 2025 | $465.0M | $538.6M | $110.9M |
| Dec 2025 | $490.4M | $605.2M | $93.0M |
| Mar 2026 | $456.5M | $555.2M | $78.4M |
| Jun 2026 | $774.8M | $799.4M | $117.7M |